ONCOTIME

Serial Number 98271002
730

Registration Progress

Application Filed
Nov 15, 2023
Under Examination
Aug 13, 2024
Approved for Publication
Jun 18, 2024
Published for Opposition
Jun 18, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Aug 13, 2025 9 days

Trademark Image

ONCOTIME

Basic Information

Serial Number
98271002
Filing Date
November 15, 2023
Published for Opposition
June 18, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Feb 13, 2025
Application
Pending
Classes
001 005 010 042

Rights Holder

Oncocyte Corporation

03
Address
15 Cushing
Irvine, CA 92618

Ownership History

Oncocyte Corporation

Original Applicant
03
Irvine, CA

Oncocyte Corporation

Owner at Publication
03
Irvine, CA

Legal Representation

Attorney
Christopher D. Olszyk, Jr.

USPTO Deadlines

Next Deadline
9 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
August 13, 2025
Extension Available
Until August 13, 2025

Application History

18 events
Date Code Type Description Documents
Feb 13, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 13, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 13, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 12, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 13, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 18, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 18, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 29, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 9, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 9, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 8, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 8, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 1, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 1, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 1, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 29, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 20, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 18, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Diagnostic reagents, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
Class 005
Research use only chemical reagents for clinical medical or veterinary purposes; diagnostic reagents for medicinal research use
Class 010
Research use only biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; Research use only cancer screening tests and devices, namely, medical devices for evaluating immunotherapy cancer treatment options; Research use only cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; Research use only medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patient
Class 042
Providing reagent sample testing and diagnostic services for others in the field of cancer testing research, tumor testing research, and screening for the purpose of evaluating patient immunotherapy cancer treatment options

Classification

International Classes
001 005 010 042